Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00787722 Background | Oct 2009 → Nov 2018 | neuromyelitis optica | Northwestern University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00787722 ↗ |
| Modality | Protein / enzyme biologic | “A glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream” NCT00787722 ↗ |